Product Images Fosinopril Sodium

This is a table presenting clinical adverse events in placebo-controlled trials for hypertension medications Fosinopril Sodium and Placebo. The table indicates the incidence of common side effects such as cough, dizziness, and nausea/vomiting and the number of patients who discontinued medication due to the side effects.*

This is a description of the incidence of adverse events in placebo-controlled trials related to heart failure. The table lists the number of patients and incidence rates for six adverse events. These include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea. The table also includes the number of patients who discontinued the treatment and the reason for discontinuation.*

The text provides information on the incidence of adverse events and discontinuation rates associated with Fosinopril Sodium Placebo. It shows the occurrence and frequency of different side effects such as Chest Pain (non-cardiac), Upper Respiratory Infection, Orthostatic Hypotension, Subjective Cardiac Rhythm Disturbance, and Weakness. The incidence rates are provided for two groups of participants (N=361 and N=373).*

This is a medication description likely retrieved from a prescription label. The medication is Fosinopril Sodium, with a strength of 20mg. It is manufactured by a company named Camber and has a National Drug Code (NDC) of 50436-3138-1. The remaining text appears to be one gibberish and not-English, possibly due to errors.*